Our findings unravel the divergent effects of GPC4 on cancer progression and clinical outcome, particularly in glioblastoma and non-small cell lung cancer, and illuminates the pleiotropic effect of GPC4 on proto-oncogene singling pathways that govern mitogenic behavior. Here, GPC4 is linked to glioblastoma.